Economic evaluation of propofol and lorazepam for critically ill patients undergoing mechanical ventilation

Critical Care Medicine

Volumn 36, Issue 3, 2008, Pages 706-714

  Cox, Christopher E ^a   Reed, Shelby D ^b   Govert, Joseph A ^c   Rodgers, Jo E ^d   Campbell Bright, Stacy ^d   Kress, John P ^e   Carson, Shannon S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

Author keywords

Artificial; Cost benefit analysis; Cost effectiveness; Critical illness; Respiration

Indexed keywords

ANALGESIC AGENT; LORAZEPAM; MIDAZOLAM; MORPHINE; PROPOFOL; SEDATIVE AGENT; HYPNOTIC SEDATIVE AGENT;

AROUSAL; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; CRITICAL ILLNESS; DRUG COST; ECONOMIC EVALUATION; HOSPITALIZATION; HUMAN; HYPERTRIGLYCERIDEMIA; INTENSIVE CARE UNIT; INTUBATION; METABOLIC ACIDOSIS; PANCREATITIS; PATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; SEDATION; SENSITIVITY ANALYSIS; SIMULATION; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DECISION TREE; ECONOMICS; MIDDLE AGED; REVIEW;

COST-BENEFIT ANALYSIS; CRITICAL ILLNESS; DECISION TREES; HUMANS; HYPNOTICS AND SEDATIVES; LORAZEPAM; MIDDLE AGED; PROPOFOL; RESPIRATION, ARTIFICIAL;

EID: 44449131048     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0B013E3181544248     Document Type: Article

References (40)

1. Angus DC, Shorr AF, White A, et al: Critical care delivery in the United States: Distribution of services and compliance with Leapfrog recommendations. Crit Care Med 2006;34:1016-1024
2. Behrendt CE: Acute respiratory failure in the United States: Incidence and 31-day survival. Chest 2000;118:1100-1105
3. Rotondi AJ, Chelluri L, Sirio C, et al: Patients' recollections of stressful experiences while receiving prolonged mechanical ventilation in an intensive care unit. Crit Care Med 2002;30:746-752
4. van de Leur JP, van der Schans CP, Loef BG, et al: Discomfort and factual recollection in intensive care unit patients. Crit Care 2004;8: R467-R473
5. Jacobi J, Fraser GL, Coursin DB, et al: Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002;30:119-141 (Pubitemid 34112188)
6. Ostermann ME, Keenan SP, Seiferling RA, et al: Sedation in the intensive care unit: A systematic review. JAMA 2000;283:1451-1459
7. Carson SS, Kress JP, Rodgers JE, et al: A randomized trial of intermittent lorazepam versus propofol with daily interruption in mechanically ventilated patients. Crit Care Med 2006;34:1326-1332
8. Kress JP, Pohlman AS, O'Connor MF, et al: Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000;342:1471-1477
9. Pandharipande P, Pun B, Herr D, et al: Double blind randomized controlled trial comparing dexmedetomidine vs. lorazepam to reduce duration of delirium and coma in mechanically ventilated patients. Abstr. In: American Thoracic Society International Conference. San Francisco, American Thoracic Society, 2007
10. Wittbrodt ET: Analysis of pharmacoeconomics of sedation and analgesia. Crit Care Clin 2001;17:1003-1013
11. Pronovost PJ: Care in the ICU: Teaming up to improve quality. Presented at: Improving Quality of Care in Intensive Care Units Through Best Practices, Washington, DC, September 4, 2002. Available at: http://www.kaisernetwork.org. Accessed July 28, 2007
12. Devlin JW, Lau AK, Tanios MA: Propofol-associated hypertriglyceridemia and pancreatitis in the intensive care unit: An analysis of frequency and risk factors. Pharmacotherapy 2005;25:1348-1352
13. Vasile B, Rasulo F, Candiani A, et al: The pathophysiology of propofol infusion syndrome: A simple name for a complex syndrome. Intensive Care Med 2003;29:1417-1425
14. Malacrida R, Fritz ME, Suter PM, et al: Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients. Crit Care Med 1992;20:1123-1126
15. Dorman T, Pauldine R: Economic stress and misaligned incentives in critical care medicine in the United States. Crit Care Med 2007;35: S36-S43
16. Angus DC, Kelley MA, Schmitz RJ, et al: Current and projected workforce requirements for care of the critically ill and patients with pulmonary disease: Can we meet the requirements of an aging population? JAMA 2000;284:2762-2770
17. Mehta S, Burry L, Fischer S, et al: Canadian survey of the use of sedatives, analgesics, and neuromuscular blocking agents in critically ill patients. Crit Care Med 2006;34:374-380
18. Torrance GW, Siegel JE, Luce BR: Framing and designing the cost-effectiveness analysis. In: Cost-effectiveness in Health and Medicine. Gold MR, Siegel JE, Russell LB, et al (Eds). New York, Oxford University Press, 1996, pp 54-81
19. Consumer price indexes. Available at: http://www.bls.gov/cpi/home.htm. Accessed March 30, 2007
20. Ramsay MA, Savege TM, Simpson BR, et al: Controlled sedation with alphaxalone-alphadolone. BMJ 1974;2:656-659
21. Barrientos-Vega R, Sanchez-Soria MM, Morales-Garcia C, et al: Pharmacoeconomic assessment of propofol 2% used for prolonged sedation. Crit Care Med 2001;29:317-322
22. Wilson KC, Reardon C, Theodore AC, et al: Propylene glycol toxicity: A severe iatrogenic illness in ICU patients receiving IV benzodiazepines. A case series and prospective, observational pilot study. Chest 2005;128:1674-1681
23. Schoenfeld DA, Bernard GR: Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med 2002;30:1772-1777
24. Average wholesale costs. Available online at: http://www.analysource.com. Accessed January 10, 2007
25. Dasta JF, McLaughlin TP, Mody SH, et al: Daily cost of an intensive care unit day: The contribution of mechanical ventilation. Crit Care Med 2005;33:1266-1271
26. Cooper LM, Linde-Zwirble WT: Medicare intensive care unit use: Analysis of incidence, cost, and payment. Crit Care Med 2004;32:2247-2253
27. Current procedural terminology online. Available at: https://catalog.ama- assn.org/Catalog/cpt/cpt-search.jsp. Accessed March 25, 2007
28. Al-Haddad M, Hayward I, Walsh TS: A prospective audit of cost of sedation, analgesia and neuromuscular blockade in a large British ICU. Anaesthesia 2004;59:1121-1125
29. Pandharipande P, Shintani A, Peterson J, et al: Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 2006;104:21-26
30. Ward NS, Levy MM: Rationing and critical care medicine. Crit Care Med 2007;35(2 Suppl):S102-S105
31. Talmor D, Shapiro N, Greenberg D, et al: When is critical care medicine cost-effective? A systematic review of the cost-effectiveness literature. Crit Care Med 2006;34:2738-2747
32. McCollam JS, O'Neil MG, Norcross ED, et al: Continuous infusions of lorazepam, midazolam, and propofol for sedation of the critically ill surgery trauma patient: A prospective, randomized comparison. Crit Care Med 1999;27:2454-2458
33. Cook DJ, Walter SD, Cook RJ, et al: Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998;129:433-440
34. Swart EL, van Schijndel RJ, van Loenen AC, et al: Continuous infusion of lorazepam versus midazolam in patients in the intensive care unit: Sedation with lorazepam is easier to manage and is more cost-effective. Crit Care Med 1999;27:1461-1465
35. Barrientos-Vega R, Mar. Sanchez-Soria M, Morales-Garcia C, et al: Prolonged sedation of critically ill patients with midazolam or propofol: Impact on weaning and costs. Crit Care Med 1997;25:33-40
36. MacLaren R, Sullivan PW: Pharmacoeconomic modeling of lorazepam, midazolam, and propofol for continuous sedation in critically ill patients. Pharmacotherapy 2005;25:1319-1328
37. Anis AH, Wang XH, Leon H, et al: Economic evaluation of propofol for sedation of patients admitted to intensive care units. Anesthesiology 2002;96:196-201
38. Siobal MS, Kallet RH, Kivett VA, et al: Use of dexmedetomidine to facilitate extubation in surgical intensive-care-unit patients who failed previous weaning attempts following prolonged mechanical ventilation: A pilot study. Respir Care 2006;51:492-496
39. Drug Topics Redbook. Oradell, NJ, Medical Economics, 2006
40. Halpern NA, Pastores SM, Greenstein RJ: Critical care medicine in the United States 1985-2000: An analysis of bed numbers, use, and costs. Crit Care Med 2004;32:1254-1259